Adcoris, a Hangzhou-based bioconjugation specialist, announced a global licensing agreement with U.S.-headquartered K2 Therapeutics, Inc....
Chia Tai Tianqing Pharmaceutical Group, a wholly owned subsidiary of Sino Biopharmaceutical Ltd (HKG: 1177),...
Beijing QL Biopharmaceutical Co., Ltd., a clinical-stage biotech founded in 2018, has filed a prospectus...
Boya Biological Pharmacy Co., Ltd., (SHE: 300294) a China-based pharmaceutical company, has agreed to divest...
Johnson & Johnson (J&J, NYSE: JNJ) announced on 24 April 2026 a definitive agreement to...
Star Sports Medicine Co., Ltd., a Chinese sports medical device manufacturer, successfully completed its initial...
Sisram Medical Ltd (HKG: 1696), an Israel-based aesthetic medical technology company and subsidiary of Fosun...
SciClone Pharmaceuticals Inc (HKG: 6600) announced a strategic partnership agreement with JD Healthcare (HKG: 6618),...
Sipai Health Technology Co., Ltd. (HKG: 0314), also known as Mebanks, has announced the sale...
AbbVie (NYSE: ABBV) has announced plans to invest $1.4 billion to construct a state-of-the-art pharmaceutical...
Merck & Co., Inc. (MSD, NYSE: MRK) has announced a multi-year strategic partnership with Google...
Boji Medical Technology Co., Ltd. (SHE: 300404), a Chinese clinical research organization (CRO), has entered...
Novabio Therapeutics and OBiO Tech, Inc. (SHA: 688238) have expanded their strategic collaboration to accelerate...
InxMed Limited, a China-based late-stage clinical biotechnology company, has filed a prospectus for an initial...
NeuroGen Pharma announced a strategic licensing agreement with Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), securing...
Eli Lilly and Company (NYSE: LLY) has agreed to acquire Kelonia Therapeutics, a clinical-stage biotechnology...
WeiMai Inc., an artificial intelligence–driven disease management company based in Hangzhou, has filed its initial...
Biogen Inc. (NASDAQ: BIIB) has finalized an agreement with TJ Biopharma, a China-based biopharmaceutical company,...
UCB (EBR: UCB) has agreed to acquire Neurona Therapeutics, a U.S.-based biotechnology company developing NRTX-1001,...
Pulnovo Medical, a Chinese pulmonary hypertension (PH) has secured over USD 100 million in an...